HOME >> MEDICINE >> NEWS
Icahn invests in the future of medicine

The Mount Sinai Medical Center today announced that foundations funded by Carl C. Icahn have committed $25 million to the Medical Center. The gift to The Mount Sinai Medical Center will help support research at Mount Sinai School of Medicine, which has the fastest growing research program in New York State. In recognition of his generosity, a state-of-the-art research building on the Mount Sinai campus, 1425 Madison Avenue, will be named The Icahn Medical Institute.

"We are delighted to receive this tremendously generous donation," said Peter W. May, the Chairman of the Boards of Trustees of The Mount Sinai Medical Center. "The fiscal challenges facing all academic medical centers give particular weight to the message of support inherent in this gift."

"This gift will help support researchers who are expanding our understanding of health and disease at the molecular, cellular, system and whole body level; identifying the underlying causes of diseases; developing new therapies; and bringing our patients tomorrow's medicine today," said Kenneth L. Davis, M.D., President and CEO of The Mount Sinai Medical Center and Dean of Mount Sinai School of Medicine.

Mr. Icahn said, "I've successfully made money through discerning which investments have the greatest potential for return. The numerous Mount Sinai generated discoveries that have been translated into improvements in patient care and its ranking among the nation's top medical schools provide an excellent basis for me to expect rich rewards for society from this investment."

A landmark of the Upper East Side skyline, the building to be named for Mr. Icahn was designed by the architectural firm Davis Brody Bond, LLP and was completed in 1997. It is home to scientists searching for answers to some of the most puzzling questions in contemporary biomedical science. This building has provided the space and facilities necessary for Mount Sinai School of Medicine to greatly expand its research progra
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
24-Feb-2004


Page: 1 2

Related medicine news :

1. Concerns over the future of childrens health care in British general practice
2. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
3. HIV vaccine trial breaks ground for future research
4. Climate change and the future of air travel
5. NIH action plan charts future challenges for liver disease research
6. Obesity in middle age may drastically raise future medicare expenditures
7. Stem cell research: The new medicine of the future
8. Chemoprevention backgrounder: Working for a future of cancer chemoprevention
9. Asymptomatic cardiovascular changes are powerful predictor of future heart disease
10. Heat-controlled drug implants offer hope for future
11. Envisat Symposium report day 3: Satellites supporting Kyoto - our future is in our forests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Icahn invests the future medicine

(Date:8/27/2015)... ... 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics Trust”) ... of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana patients ... and tablets. Well, Doobster, “The App That Delivers!” is here! You ...
(Date:8/27/2015)... ... ... The Naderi Center is proud to announce that its own Dr. Jessica ... fat. The first and only Food and Drug Administration (FDA) approved treatment for ... only Board Certified surgeon in the D.C., Maryland, Virginia area to offer this innovative, ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, ... Glushko, professional Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko ... her training and recovery. , With a focus on technology and comfort, Zensah® ...
(Date:8/27/2015)... OKLAHOMA CITY, OK (PRWEB) , ... August 27, ... ... Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract development manufacturing company ... acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. , ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Susan Harris ... procedure to relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and child birth. ... CO2 laser, which delivers controlled energy to the vaginal tissue, revitalizing cells so they ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and ... at a legal conference in Philadelphia ... emerging issues, Tom Hagy of HB Litigation Conferences ... event, visit HB,s website at http://litigationconferences.com/?p=31886 ... Segal McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... 27, 2015 Itamar Medical Ltd. ... investment in public equity (PIPE) deal, in which Viola ... Itamar Medical.   Through this deal, Viola ... Medical and will work closely with the company,s management ... to the investment agreement, Itamar Medical will issue shares ...
(Date:8/27/2015)... , August 27, 2015 ... Persistence Market Research titled "Global Market Study on ... Growth by 2021", the urinary catheters market is expected to ... of 2015. It is anticipated to expand at ... reach US$1,755.0 Mn by 2021. View ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
Cached News: